Siren »

Gossamer Bio shares owned by Siren

Quarter-by-quarter ownership of Gossamer Bio (GOSS) shares owned by Siren from 13F filings

Historical chart of Siren investment in Gossamer Bio

Tip: Access up to 7 years of quarterly data

All positions including Gossamer Bio held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gossamer Bio by Siren

Quarter filed Position value Share count Share price at filing
2024-09-30 $13M 14M 0.99

More positions owned by Siren

Kymera Therapeutics (KYMR)
Beigene Sponsored Adr (BGNE)
Scholar Rock Hldg Corp (SRRK)
Bicara Therapeutics
Argenx SE Sponsored Adr (ARGX)
Crinetics Pharmaceuticals In (CRNX)
Avidity Biosciences Ord (RNA)
Apellis Pharmaceuticals (APLS)
Lexicon Pharmaceuticals Com New (LXRX)
Igm Biosciences (IGMS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Ascendis Pharma A/S Sponsored Adr (ASND)
Silence Therapeutics Ads (SLN)
Arrowhead Pharmaceuticals (ARWR)
WAVE Life Sciences SHS (WVE)

View all positions for Siren

Top funds holding Gossamer Bio

NEA Management Company
Siren
Vanguard Group
Octagon Capital Advisors
Arch Venture Corp
T. Rowe Price Associates
Palo Alto Investors
Samsara BioCapital
683 Capital Management
Alyeska Investment Group
Silverarc Capital Management
Hillhouse Capital Advisors
Acadian Asset Management
Monaco Asset Management SAM
Opaleye Management

View all funds holding Gossamer Bio